This review discusses the efficacy of anticoagulation therapy and its alternatives in patients with atrial fibrillation and flutter, including strategies surrounding catheter ablation and cardioversion.
Answers are grounded in this paper and cite their sources.
Supports individualized periprocedural decisions in AF; leaves open optimal alternatives pending new trials.
Atrial fibrillation and atrial flutter are important risk factors for stroke. Based on a literature search, pathogenesis of thromboembolism, risk assessment in patients, efficacy of anticoagulation therapy and its alternatives are discussed. Special emphasis is put on issues like paroxysmal atrial fibrillation, atrial flutter and anticoagulation surrounding catheter ablation and cardioversion. A strategy for anticoagulation around the time of pulmonary vein ablation is suggested.
No takes yet. Share an insight, caveat, or question.
Scholten et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: